Harness Biotech Congratulates McLain Ward on Another Win at American Gold Cup

North Salem, N.Y. / Vancouver, B.C. - Sept. 17, 2019 - The Team at Harness Biotech would like to congratulate two-time Olympic gold medalist McLain Ward for defending his title as the First Prize winner of the $71,200 Fidelity Investments® Classic CSI4* at the American Gold Cup and his new horse, Franka Trichta.

“McLain Ward is an icon in the world of show jumping and we couldn’t be more pleased to see his success again at Old Salem Farm. The team at Harness feels privileged to play a supporting role by providing Velocity to aid in his horses recovery and overall performance” - Greg Bobolo, Harness Executive Chairman.

Ward, who came in both first and second in July at the Canadian Utilities Cup at the Pan American Tournament in Spruce Meadows Alberta with horses HH Azur and Contagious, is an ardent user of Harness’s Velocity Gel. This revolutionary formula is the only product of its kind; a gel that can distribute Carnosine through topical application. Carnosine helps to put out the burning fire in the equine athlete’s muscles that is felt before reaching failure and as a result enhances muscular performance.

“Velocity has dramatically helped my horses’ recovery and performance and has become part of our daily routine,” says Ward, who uses Velocity on all of his horses.


Ward's Barn Manager, Lee McKeever, shares his sentiments. McKeever says, "Azur got hurt last year; she tore a muscle in her back. It was a slow process coming back, getting her back into shape; we heard about the Velocity gel in January and started using it right away. We saw a dramatic change in recovery time and overall performance, that’s what sold it for us, and we started using it on all our horses daily."   


About Velocity

Harness Performance and Recovery Gel, Velocity is the only product of its kind; a gel that can distribute Carnosine through topical application. Velocity is now available at https://www.harnessbiotech.com


About Harness Biotechnologies Inc.

A global innovation-driven biotechnology company dedicated to improving equine performance. Harness Biotechnology Inc. researches, licenses, develops and commercializes one-of-a-kind scientific performance and recovery treatments for the equine industry. Harness, is the official global rights holder and licensor of a patent pending one-of-a-kind 100% natural performance and recovery gels for topical application and distribution of Carnosine. Harness products are made in the USA and contain no prohibited substances.

Carnosine has been widely studied for its effects on improved wound healing, antioxidant activity and its anti-aging properties since the early 1900s. As the official global rights holder and licensor of the Carnosine complex, Harness Biotech is proud to be the first entity to successfully develop a topical application that directly (and almost immediately) increases levels of Carnosine in the muscle of horses.

Media Contact
David Davies

VP Corporate Communications
502.378.3694
david.davies@harnessbiotech.com